Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.059 | 0.7 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.058 | 0.7 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |